Elevated metal concentrations in the CF airway correlate with cellular injury and disease severity

Journal of Cystic Fibrosis

Volumn 13, Issue 3, 2014, Pages 289-295

  Smith, Daniel J ^a,b,c   Anderson, Gregory J ^b,c   Bell, Scott C ^a,b,d   Reid, David W ^a,b,c  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Bio metals; Cellular injury; Cystic Fibrosis; Inflammation

Indexed keywords

CALCIUM; INTERLEUKIN 8; LACTATE DEHYDROGENASE; MAGNESIUM; METAL; MOLYBDENUM; ZINC; BIOLOGICAL MARKER; IL8 PROTEIN, HUMAN; IRON;

ADULT; ARTICLE; BRONCHIECTASIS; CELL DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATORY CELL; LUNG FUNCTION; MALE; MASS SPECTROMETRY; PARTICULATE MATTER; RESPIRATORY TRACT INFLAMMATION; SPUTUM ANALYSIS; TISSUE NECROSIS; ADOLESCENT; AGED; CROSS-SECTIONAL STUDY; LUNG FUNCTION TEST; METABOLISM; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SPUTUM; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; FEMALE; HUMANS; INTERLEUKIN-8; IRON; L-LACTATE DEHYDROGENASE; MAGNESIUM; MALE; MIDDLE AGED; MOLYBDENUM; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SPUTUM; YOUNG ADULT; ZINC;

EID: 84897110610     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2013.12.001     Document Type: Article

References (46)

1. Flume P.A., Mogayzel P.J., Robinson K.A., Goss C.H., Rosenblatt R.L., Kuhn R.J., et al. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med 2009, 180(9):802-808.
2. Mott L.S., Park J., Murray C.P., Gangell C.L., de Klerk N.H., Robinson P.J., et al. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax 2012, 67(6):509-516.
3. Cystic Fibrosis Foundation patient registry (2010): annual data report 2012, The Cystic Fibrosis Foundation, Bethesda, Maryland, USA.
4. Pressler T. Targeting airway inflammation in cystic fibrosis in children: past, present, and future. Paediatr Drugs 2011, 13(3):141-147.
5. Sanderson K., Wescombe L., Kirov S.M., Champion A., Reid D.W. Bacterial cyanogenesis occurs in the cystic fibrosis lung. Eur Respir J 2008, 32(2):329-333.
6. Worlitzsch D., Tarran R., Ulrich M., Schwab U., Cekici A., Meyer K.C., et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 2002, 109(3):317-325.
7. Fraga C.G. Relevance, essentiality and toxicity of trace elements in human health. Mol Aspects Med 2005, 26(4-5):235-244.
8. Gray R.D., Duncan A., Noble D., Imrie M., O'Reilly D.S., Innes J.A., et al. Sputum trace metals are biomarkers of inflammatory and suppurative lung disease. Chest 2010, 137(3):635-641.
9. Reid D.W., Carroll V., O'May C., Champion A., Kirov S.M. Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis. Eur Respir J 2007, 30(2):286-292.
10. Glick R., Gilmour C., Tremblay J., Satanower S., Avidan O., Deziel E., et al. Increase in rhamnolipid synthesis under iron-limiting conditions influences surface motility and biofilm formation in Pseudomonas aeruginosa. J Bacteriol 2010, 192(12):2973-2980.
11. Smith D.J., Lamont I.L., Anderson G.J., Reid D.W. Targeting iron uptake to control Pseudomonas aeruginosa infections in cystic fibrosis. Eur Respir J 2013, 46(6):1723-1736.
12. Dieppois G., Ducret V., Caille O., Perron K. The transcriptional regulator CzcR modulates antibiotic resistance and quorum sensing in Pseudomonas aeruginosa. PLoS One 2012, 7(5):e38148.
13. Jomova K., Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011, 283(2-3):65-87.
14. Kinnula V.L., Crapo J.D. Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med 2003, 167(12):1600-1619.
15. MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 2001, 429(1-3):195-207.
16. Iobbi-Nivol C., Leimkuhler S. Molybdenum enzymes, their maturation and molybdenum cofactor biosynthesis in Escherichia coli. Biochim Biophys Acta 2013, 1827(8-9):1086-1101.
17. Stojanovic D., Nikic D., Lazarevic K. The level of nickel in smoker's blood and urine. Cent Eur J Public Health 2004, 12(4):187-189.
18. Chen L.C., Lippmann M. Effects of metals within ambient air particulate matter (PM) on human health. Inhal Toxicol 2009, 21(1):1-31.
19. Pizzichini E., Pizzichini M.M., Efthimiadis A., Hargreave F.E., Dolovich J. Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J 1996, 9(6):1174-1180.
20. Domej W., Krachler M., Schlagenhaufen C., Trinker M., Krejs G.J., Irogolic K.J. Trace elements in pleural effusions. J Trace Elem Med Biol 1997, 11(4):232-238.
21. Rodushkin I., Odman F., Branth S. Multielement analysis of whole blood by high resolution inductively coupled plasma mass spectrometry. Fresenius J Anal Chem 1999, 364(4):338-346.
22. Minoia C., Sabbioni E., Apostoli P., Pietra R., Pozzoli L., Gallorini M., et al. Trace element reference values in tissues from inhabitants of the European community. I. A study of 46 elements in urine, blood and serum of Italian subjects. Sci Total Environ 1990, 95:89-105.
23. Prohaska C., Pomazal K., Steffan I. Determination of Ca, Mg, Fe, Cu, and Zn in blood fractions and whole blood of humans by ICP-OES. Fresenius J Anal Chem 2000, 367(5):479-484.
24. Goulle J.P., Mahieu L., Castermant J., Neveu N., Bonneau L., Laine G., et al. Metal and metalloid multi-elementary ICP-MS validation in whole blood, plasma, urine and hair. Reference values. Forensic Sci Int 2005, 153(1):39-44.
25. Hood M.I., Skaar E.P. Nutritional immunity: transition metals at the pathogen-host interface. Nat Rev Microbiol 2012, 10(8):525-537.
26. Wark P.A., Johnston S.L., Moric I., Simpson J.L., Hensley M.J., Gibson P.G. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 2002, 19(1):68-75.
27. Pukhalsky A.L., Kapranov N.I., Kalashnikova E.A., Shmarina G.V., Shabalova L.A., Kokarovtseva S.N., et al. Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection. Mediators Inflamm 1999, 8(3):159-167.
28. Reid D.W., Lam Q.T., Schneider H., Walters E.H. Airway iron and iron-regulatory cytokines in cystic fibrosis. Eur Respir J 2004, 24(2):286-291.
29. Moreau-Marquis S., Bomberger J.M., Anderson G.G., Swiatecka-Urban A., Ye S., O'Toole G.A., et al. The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability. Am J Physiol Lung Cell Mol Physiol 2008, 295(1):L25-L37.
30. Kim J., Molina R.M., Donaghey T.C., Buckett P.D., Brain J.D., Wessling-Resnick M. Influence of DMT1 and iron status on inflammatory responses in the lung. Am J Physiol Lung Cell Mol Physiol 2011, 300(4):L659-L665.
31. Sardesai V.M. Molybdenum: an essential trace element. Nutr Clin Pract 1993, 8(6):277-281.
32. Yoshida M., Ota S., Fukunaga K., Nishiyama T. Serum molybdenum concentration in healthy Japanese adults determined by inductively coupled plasma-mass spectrometry. J Trace Elem Med Biol 2006, 20(1):19-23.
33. Schobert M., Jahn D. Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung. Int J Med Microbiol 2010, 300(8):549-556.
34. Noriega C., Hassett D.J., Rowe J.J. The mobA gene is required for assimilatory and respiratory nitrate reduction but not xanthine dehydrogenase activity in Pseudomonas aeruginosa. Curr Microbiol 2005, 51(6):419-424.
35. Tunney M.M., Field T.R., Moriarty T.F., Patrick S., Doering G., Muhlebach M.S., et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 2008, 177(9):995-1001.
36. Stites S.W., Plautz M.W., Bailey K., O'Brien-Ladner A.R., Wesselius L.J. Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis. Am J Respir Crit Care Med 1999, 160(3):796-801.
37. Stites S.W., Walters B., O'Brien-Ladner A.R., Bailey K., Wesselius L.J. Increased iron and ferritin content of sputum from patients with cystic fibrosis or chronic bronchitis. Chest 1998, 114(3):814-819.
38. Tam M., Gomez S., Gonzalez-Gross M., Marcos A. Possible roles of magnesium on the immune system. Eur J Clin Nutr 2003, 57(10):1193-1197.
39. Bussiere F.I., Gueux E., Rock E., Girardeau J.P., Tridon A., Mazur A., et al. Increased phagocytosis and production of reactive oxygen species by neutrophils during magnesium deficiency in rats and inhibition by high magnesium concentration. Br J Nutr 2002, 87(2):107-113.
40. Mulcahy H., Lewenza S. Magnesium limitation is an environmental trigger of the Pseudomonas aeruginosa biofilm lifestyle. PLoS One 2011, 6(8):e23307.
41. Johnson M.D., Garrett C.K., Bond J.E., Coggan K.A., Wolfgang M.C., Redinbo M.R. Pseudomonas aeruginosa PilY1 binds integrin in an RGD- and calcium-dependent manner. PLoS One 2011, 6(12):e29629.
42. Sarkisova S., Patrauchan M.A., Berglund D., Nivens D.E., Franklin M.J. Calcium-induced virulence factors associated with the extracellular matrix of mucoid Pseudomonas aeruginosa biofilms. J Bacteriol 2005, 187(13):4327-4337.
43. Denning G.M., Railsback M.A., Rasmussen G.T., Cox C.D., Britigan B.E. Pseudomonas pyocyanine alters calcium signaling in human airway epithelial cells. Am J Physiol 1998, 274(6 Pt 1):L893-L900.
44. Abdulhamid I., Beck F.W., Millard S., Chen X., Prasad A. Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis. Pediatr Pulmonol 2008, 43(3):281-287.
45. Holgate S.T., Yang Y., Haitchi H.M., Powell R.M., Holloway J.W., Yoshisue H., et al. The genetics of asthma: ADAM33 as an example of a susceptibility gene. Proc Am Thorac Soc 2006, 3(5):440-443.
46. Sagel S.D., Chmiel J.F., Konstan M.W. Sputum biomarkers of inflammation in cystic fibrosis lung disease. Proc Am Thorac Soc 2007, 4(4):406-417.